COMPARİSON OF HEART FAİLURE PATİENTS AND HEALTHY PEOPLE İN BALANCE AND GAİT PARAMETERS

Hacettepe University

Status: Completed

Conditions: Heart Failure,Balance

Study type: Observational

Funder types: Other

Identifiers

NCT03853759

GO 18/736-06

Details and patient eligibility

About

We aimed to show the difference between balance and gait parameters in heart failure and healthy individuals.

Full description

Heart failure is the inability of the heart to pump a sufficient amount of blood into our body. The reason is usually the decrease in the contractile capacity of myocardium due to decreased coronary blood flow. Symptoms and symptoms may be quite diverse in the underlying pathophysiology of heart failure, which is usually the only type. As a result of heart failure; problems such as dyspnoea, anemia, peripheral edema, peripheral muscle involvement and decreased muscle mass, confusion, sleep disorder, dementia, various cardiac symptoms and renal failure can be seen.

Balance body with minimal muscle activity in static or dynamic position on the support base is to maintain the center of gravity. Patients with heart failure may have decreased postural control, exercise intolerance, breathing problems, and decreased cognitive function.

Gait analysis, evaluation of neuro musculoskeletal system functions and interpretation of results with numbers and graphs. Gait analysis is an analysis method that plays a role in many cases of clinical diagnosis and follow-up. Heart failure is characterized by a significant reduction in walking distance, which leads to reduced quality of life. In a study conducted in heart failure, it is stated that gait velocity is a determinant of one year mortality and hospitalization, and should be considered for clinical evaluations and prognosis. All these causes of heart failure in chronic disease groups defined considering it is important to investigate the balance and gait parameters.

This study will show the difference between the balance and walking parameters in heart failure according to the healthy participants.

Enrollment: 44 patients

Sex: All

Ages: 18 to 79 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ejection fraction <40% or less,
• Without acute decompensation,
• No revascularization in the last six months,
• The drug has been stable for the last four weeks,
• Accepts participation in the study,
• Coopere,
• NewYork Heart Association -NYHA Class II- III
• Patients with heart failure who are amputated without support or assistive devices will be included in the study.

Exclusion criteria

• Neurological, cognitive or orthopedic diseases that affect the measurements,
• Severe respiratory disease (FEV1 <35%),
• BNP> 100pg / ml and above,
• Acute infection,
• Resting heart rate above 140 beats / min,
• Dementia,
• Having a BMI> 35 or above,
• Individuals with other chronic diseases that may affect their balance and walking will not be included in the study.

Trial design

44 participants in 2 patient groups

Patients with Heart Failure

Healthy İndividuals